Wanganui

Main Menu

  • Creative Destruction
  • Tax Haven
  • Terminal Value
  • First Theorem Of Welfare Economics
  • Debt

Wanganui

Header Banner

Wanganui

  • Creative Destruction
  • Tax Haven
  • Terminal Value
  • First Theorem Of Welfare Economics
  • Debt
Creative Destruction
Home›Creative Destruction›New Startups, Funding, Mergers, Clinical Trials, Partnerships – GeekWire

New Startups, Funding, Mergers, Clinical Trials, Partnerships – GeekWire

By Judy Grier
June 11, 2022
0
0
A protein (purple) interacting with a small molecule, a potential drug (green), visualized in Charm Therapeutics’ DragonFold tool. (charm picture)

Here’s a look at life sciences and health news in the Pacific Northwest this week.

Partnerships:

  • Seattle-based DNA sequencing companies TwinStrand Biosciences and Singular Genomics have teamed up to develop ultra-sensitive tests to detect rare genetic variants. One application is the detection of “minimal residual disease” in tumor cells and DNA in the bloodstream.
  • Seattle-based Umoja Biopharma and TreeFrog Therapeutics are combining technology to create new cell therapies from human-induced pluripotent stem cells, virgin cells that can be grown into different cell types. Umoja has a way to turn these cells into therapeutic immune cells, and TreeFrog can grow them in large quantities.

Abstracts from the American Society of Clinical Oncology (ASCO):

Clinical tests:

  • People aged six months to 49 years will be assessed in a study asking how well COVID-19 vaccines protect against the disease, especially in children, and how the immune system responds after infection. The multicenter study will recruit 3,500 people in the Seattle and Portland areas.
  • Cell therapy company Sonoma Biotherapeutics has received the green light from the US Food and Drug Administration for a preliminary trial of its biologic SBT115301. SBT115301 is designed to eliminate highly active immune cells found in autoimmune and inflammatory diseases, for treatment with immune-calming “regulatory” T cell-derived cells.

Publications:

  • Researchers from the Seattle Children’s Research Institute and their colleagues rated isoflurane, a common anesthetic. The gas inhibits a key protein complex in the mitochondria, the cell’s energy-producing factories, leading to effects on neurons.
  • Baker, director of the Institute for Protein Design at UW, and his colleagues wrote a review article in Nature explore how to design effective enzymes from scratch.

New manufacturing center:

  • Swiss biomanufacturing giant Lonza has expanded its plant in Bend, Oregon, adding a new center focused on improving the delivery of oral or inhaled small molecules.

Closed for business:

  • Washington State Attorney General Bob Ferguson has won $500,000 for people who paid for unproven stem cell treatments from a company that ran the no longer licensed Seattle Stem Cell Center to commercialize such treatments.

Events and deadlines:

Related posts:

  1. A maternity and clever loan
  2. Non – bank loans immediately on account
  3. 6 most important information about your loan to watch
  4. This is Why High Union Electronics (GTSM: 6266) Can Responsibly Handle Debt

Recent Posts

  • How 2022 differs from 2018
  • Is there an opportunity with the 50% undervaluation of Wallbox NV (NYSE: WBX)?
  • Off-season shifts Wafer prices rise, 1Q22 smelter production value up 8.2% QoQ, according to TrendForce
  • The ultimate challenge
  • The intrinsic value of Midwich Group plc (LON:MIDW) is potentially 69% higher than its share price

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • July 2019
  • June 2019
  • April 2019
  • February 2019
  • January 2019
  • September 2018
  • December 2017
  • October 2017
  • March 2017
  • February 2017
  • December 2016
  • August 2016
  • May 2016
  • April 2016
  • October 2015
  • May 2015
  • April 2015
  • November 2014
  • September 2013
  • August 2010

Categories

  • Creative Destruction
  • Debt
  • First Theorem Of Welfare Economics
  • Tax Haven
  • Terminal Value
  • Terms and Conditions
  • Privacy Policy